2012, Volume 5, Issue 1, pp 79 – 81

European dimension of cannabinoid-like products use

SCImago Journal & Country Rank

Issues

Special Issues

Authors and Affiliations

Correspondence to:Surugiu Madi Elena, MD “Carol Davila” University of Medicine and Pharmacy, Bucharest, 1-3 Dr. Leonte Street, District 5, Romania Phone: 4021 - 318 07 13; Mobile: +40 724 808 703; E-mail: madi.surugiu@mai.gov.ro

Abstract

The use of new psychoactive substances and the new patterns of drug use can have important public health and policy implications. Few countries have monitoring systems that are sensitive to this new phenomenon in the drug field, but methodological difficulties to detect them are considerable. Nonetheless, the importance of identifying potential new threats is widely recognized. The European Union’s Early-Warning System (EWS) provides a quick-response mechanism to the emergence of new psychoactive substances on the drug scene. The European Council’s decision on new psychoactive substances establishes a mechanism for the rapid exchange of information on new drugs. It also provides the possibility to trigger a formal risk assessment process, the findings of which may lead to a political decision to place new substances under control across the European Union.

Abbreviations EWS – Early-Warning System, THC – Tetrahydrocannabinol, EMCDDA – European Monitoring Center for Drugs and Drug Addiction

Keywords

About this article

PMC ID: 3307084
PubMed ID: 22574091
DOI: 

Article Publishing Date (print): 22-02-2012
Available Online: 05-03-2012

Journal information

ISSN Printing: 1844-122X
ISSN Online: 1844-3117
Journal Title: Journal of Medicine and Life

Copyright License: Open Access

This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use and redistribution provided that the original author and source are credited.


SCImago Journal & Country Rank

Issues

Special Issues